Cargando…
Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
Introduction: To explore the involvement of the cardiovascular system in coronavirus disease 2019 (COVID-19), we investigated whether myocardial injury occurred in COVID-19 patients and assessed the performance of serum high-sensitivity cardiac Troponin I (hs-cTnI) levels in predicting disease sever...
Autores principales: | Cao, Jiatian, Zheng, Yan, Luo, Zhe, Mei, Zhendong, Yao, Yumeng, Liu, Zilong, Liang, Chao, Yang, Hongbo, Song, Yanan, Yu, Kaihuan, Gao, Yan, Zhu, Chouwen, Huang, Zheyong, Qian, Juying, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449913/ https://www.ncbi.nlm.nih.gov/pubmed/32863952 http://dx.doi.org/10.7150/thno.47980 |
Ejemplares similares
-
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020) -
Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension
por: Huang, Zheyong, et al.
Publicado: (2020) -
Low CD4 T cell count predicts radiological progression in severe and critically ill COVID-19 patients: a case control study
por: Wang, Qingqing, et al.
Publicado: (2021) -
High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
por: Johannsen, Jessika, et al.
Publicado: (2023) -
Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)
por: Tannenberg, Robert, et al.
Publicado: (2023)